Home infusions for lung cancer: a small study tests feasibility
NCT ID NCT03786653
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looked at whether immunotherapy for bronchial (lung) cancer can be given at home instead of in a hospital. Ten patients who were already stable on treatment received their infusions at home. Researchers tracked how many had to stop home care for medical reasons, monitored side effects, and measured quality of life and satisfaction.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- immunotherapy
- What this could lead to
- If successful, this could show that home-based immunotherapy is a safe and convenient option for some lung cancer patients, potentially reducing hospital visits.
- What could go wrong
- This is a very small, early observational study with only 10 participants. It does not test if the treatment works, only if giving it at home is practical. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHIAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre hospitalier de pau
Pau, Aquitaine, 64160, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.